Langhans Linnea, Jensen Maj-Britt, Talman Maj-Lis M, Vejborg Ilse, Kroman Niels, Tvedskov Tove F
Department of Plastic Surgery, Breast Surgery and Burns, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Danish Breast Cancer Cooperative Group, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
JAMA Surg. 2017 Apr 1;152(4):378-384. doi: 10.1001/jamasurg.2016.4751.
New techniques for preoperative localization of nonpalpable breast lesions may decrease the reoperation rate in breast-conserving surgery (BCS) compared with rates after surgery with the standard wire-guided localization. However, a valid reoperation rate for this procedure needs to be established for comparison, as previous studies on this procedure include a variety of malignant and benign breast lesions.
To determine the reoperation rate after wire-guided BCS in patients with histologically verified nonpalpable invasive breast cancer (IBC) or ductal carcinoma in situ (DCIS) and to examine whether the risk of reoperation is associated with DCIS or histologic type of the IBC.
DESIGN, SETTING, AND PARTICIPANTS: This nationwide study including women with histologically verified IBC or DCIS having wire-guided BCS performed between January 1, 2010, and December 31, 2013, used data from the Danish National Patient Registry that were cross-checked with the Danish Breast Cancer Group database and the Danish Pathology Register.
Reoperation rate after wire-guided BCS in patients with IBC or DCIS.
Wire-guided BCS was performed in 4118 women (mean [SD] age, 60.9 [8.7] years). A total of 725 patients (17.6%) underwent a reoperation: 593 were reexcisions (14.4%) and 132 were mastectomies (3.2%). Significantly more patients with DCIS (271 of 727 [37.3%]) than with IBC (454 of 3391 [13.4%]) underwent a reoperation (adjusted odds ratio, 3.82; 95% CI, 3.19-4.58; P < .001). After the first reexcision, positive margins were still present in 97 patients (16.4%). The risk of repeated positive margins was significantly higher in patients with DCIS vs those with IBC (unadjusted odds ratio, 2.21; 95% CI, 1.42-3.43; P < .001). The risk of reoperation was significantly increased in patients with lobular carcinoma vs those with ductal carcinoma (adjusted odds ratio, 1.44; 95% CI 1.06-1.95; P = .02). A total of 202 patients (4.9%) had a subsequent completion mastectomy, but no difference was found in the type of reoperation between patients with DCIS and those with IBC.
A lower reoperation rate after wire-guided BCS was found in this study than those shown in previous studies. However, the risk of reoperation in patients with DCIS was 3 times higher than in those with IBC. The widespread use of mammographic screening will increase the number of patients diagnosed with DCIS, making a precise localization of nonpalpable DCIS lesions even more important.
与标准金属丝引导定位手术相比,术前对不可触及乳腺病变进行定位的新技术可能会降低保乳手术(BCS)的再次手术率。然而,由于此前关于该手术的研究涵盖了各种恶性和良性乳腺病变,因此需要确定该手术的有效再次手术率以进行比较。
确定经组织学证实为不可触及的浸润性乳腺癌(IBC)或原位导管癌(DCIS)患者在接受金属丝引导的BCS术后的再次手术率,并检查再次手术风险是否与DCIS或IBC的组织学类型相关。
设计、地点和参与者:这项全国性研究纳入了在2010年1月1日至2013年12月31日期间接受金属丝引导BCS且经组织学证实为IBC或DCIS的女性,使用了丹麦国家患者登记处的数据,并与丹麦乳腺癌组数据库和丹麦病理登记处进行了交叉核对。
IBC或DCIS患者接受金属丝引导的BCS术后的再次手术率。
4118名女性接受了金属丝引导的BCS(平均[标准差]年龄为60.9[8.7]岁)。共有725名患者(17.6%)接受了再次手术:593例为再次切除(14.4%),132例为乳房切除术(3.2%)。接受再次手术的DCIS患者(727例中的271例[37.3%])明显多于IBC患者(3391例中的454例[13.4%])(调整后的优势比为3.82;95%置信区间为3.19 - 4.58;P < 0.001)。首次再次切除后,97例患者(16.4%)仍存在切缘阳性。DCIS患者再次出现切缘阳性的风险明显高于IBC患者(未调整的优势比为2.21;95%置信区间为1.42 - 3.43;P < 0.001)。小叶癌患者的再次手术风险明显高于导管癌患者(调整后的优势比为1.44;95%置信区间为1.06 - 1.95;P = 0.02)。共有202例患者(4.9%)随后接受了乳房全切术,但DCIS患者和IBC患者之间的再次手术类型没有差异。
本研究发现金属丝引导的BCS术后再次手术率低于此前研究。然而,DCIS患者的再次手术风险是IBC患者的3倍。乳腺钼靶筛查的广泛应用将增加被诊断为DCIS的患者数量,使得精确定位不可触及的DCIS病变变得更加重要。